To Establish a Multicenter Registry to Evaluate the Impact of Photodynamic Therapy in the Management of Patients With Unresectable Cholangiocarcinoma
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Porfimer sodium (Primary) ; Photosensitisers
- Indications Cholangiocarcinoma
- Focus Adverse reactions
- Acronyms PDTRegistry
- 16 Feb 2017 Planned End Date changed from 1 Dec 2016 to 30 Dec 2018.
- 16 Feb 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2018.
- 11 Jun 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.